August 30, 2026

Video

Beyond the Data: SWITCH-SWEDEHEART

15:27

Mamas Mamas, Elmir Omerovic, and Jurriën ten Berg discuss the impact of policies switching from ticagrelor to prasugrel as the default antiplatelet choice for ACS patients undergoing PCI.

Jurriën ten Berg

Elmir Omerovic

esc 2026

mamas Mamas

beyond the data

Interview

Advertisement

Latest Videos

18:44

Behind the Science: Managing Failed Transcatheter Aortic Valves

10:51

Behind the Science: Patterns and Timing of Sequential Transcatheter Valve Interventions

04:15

Behind the Science Flashback: The Impact of Prosthesis-Patient Mismatch on TAVR Durability

03:29

Behind the Science Flashback: Results From the EXPANDed Studies

07:58

Quick Takes: Gaps in Hispanic/Latino CVD Care

19:12

Behind the Science: Trends in Isolated and Combined AVR in Patients Under 65 Years

19:51

Behind the Science: Frailty and Social Vulnerability in Medicare Beneficiaries Undergoing TAVR

09:50

On Record: AI's Imprint on Medical Education

08:08

Quick Takes: Trends and Disparities in Aortic Stenosis-Related Mortality

06:20

Quick Takes: The Shifting Burdens of Major Lower Extremity Amputations

14:36

Beyond the Data: NOTION-4

03:29

Cardialogue: Impacts of Extreme Heat on CV Health

Partner Content

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.